Editorial: Myocardium regeneration and cardioprotection

Martina Iengo^#¹, Ester Topa^#¹, Alessandra Cuomo¹, Maria Cristina Luise¹, Francesco Fiore¹, Marika Rizza¹, Mattia Miccio¹, Elena Di Sarro¹, Giuseppe Ciaccio¹, Chiara Di Lorenzo¹, Valentina Mercurio^{1

2

3}, Sang-Bing Ong^{4

5

6

7

8}, Serena Zacchigna^{9

10}, Carlo Gabriele Tocchetti^{1

2

3

11}

Affiliations

¹ Department of Translational Medical Sciences, Federico II University, Naples, Italy.
² Interdepartmental Center of Clinical and Translational Sciences (CIRCET), Federico II University, Naples, Italy.
³ Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University, Naples, Italy.
⁴ Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, China.
⁵ Centre for Cardiovascular Genomics and Medicine (CCGM), Lui Che Woo Institute of Innovative Medicine, Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
⁶ Hong Kong Hub of Paediatric Excellence (HK HOPE), Hong Kong Children's Hospital (HKCH), Kowloon Bay, Hong Kong SAR, China.
⁷ Kunming Institute of Zoology-The Chinese University of Hong Kong (KIZ-CUHK) Joint Laboratory of Bioresources and Molecular Research of Common Diseases, Hong Kong SAR, China.
⁸ Neural, Vascular, and Metabolic Biology Thematic Research Program, School of Biomedical Sciences (SBS), Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
⁹ International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
¹⁰ Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
¹¹ Center for Basic and Clinical Immunology Research (CISI), Federico II University, Naples, Italy.

^# Contributed equally.

PMID: 39086692
PMCID: PMC11285539
DOI: 10.3389/fmmed.2023.1293183

Editorial

Editorial: Myocardium regeneration and cardioprotection

Martina Iengo et al. Front Mol Med. 2023.

. 2023 Oct 9:3:1293183.

doi: 10.3389/fmmed.2023.1293183. eCollection 2023.

Authors

Affiliations

¹ Department of Translational Medical Sciences, Federico II University, Naples, Italy.
² Interdepartmental Center of Clinical and Translational Sciences (CIRCET), Federico II University, Naples, Italy.
³ Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University, Naples, Italy.
⁴ Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, China.
⁵ Centre for Cardiovascular Genomics and Medicine (CCGM), Lui Che Woo Institute of Innovative Medicine, Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
⁶ Hong Kong Hub of Paediatric Excellence (HK HOPE), Hong Kong Children's Hospital (HKCH), Kowloon Bay, Hong Kong SAR, China.
⁷ Kunming Institute of Zoology-The Chinese University of Hong Kong (KIZ-CUHK) Joint Laboratory of Bioresources and Molecular Research of Common Diseases, Hong Kong SAR, China.
⁸ Neural, Vascular, and Metabolic Biology Thematic Research Program, School of Biomedical Sciences (SBS), Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
⁹ International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
¹⁰ Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
¹¹ Center for Basic and Clinical Immunology Research (CISI), Federico II University, Naples, Italy.

^# Contributed equally.

PMID: 39086692
PMCID: PMC11285539
DOI: 10.3389/fmmed.2023.1293183

No abstract available

Keywords: cardiomyocytes; cardioprotection; heart failure; myocardium regeneration; stem cells.

PubMed Disclaimer

Conflict of interest statement

CGT reports honoraria or consultation fees from VivaLyfe, Univers Formazione, Solaris, Summeet, Astra Zeneca, Myocardial Solutions, Medtronic; funding from Amgen and MSD, outside the submitted work; and is listed as an inventor of two patents related to heart failure. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

Editorial on the Research Topic Myocardium Regeneration and Cardioprotection

References

1. Ciucci G., Colliva A., Vuerich R., Pompilio G., Zacchigna S. (2022). Biologics and cardiac disease: challenges and opportunities. Trends Pharmacol. Sci. 43 (11), 894–905. 10.1016/j.tips.2022.06.001 - DOI - PubMed
1. Gabisonia K., Prosdocimo G., Donato Aquaro G., Carlucci L., Zentilin L., Secco I., et al. (2019). MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs. Nature 569 (7756), 418–422. 10.1038/s41586-019-1191-6 - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Frontiers Media SA
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Editorial: Myocardium regeneration and cardioprotection

Affiliations

Editorial: Myocardium regeneration and cardioprotection

Authors

Affiliations

Conflict of interest statement

Comment on

References

Publication types

LinkOut - more resources

Full Text Sources